MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for controlling mixed dyslipidemia
Disease control CompletedThis study tested a new drug called plozasiran in 353 adults with mixed dyslipidemia, a condition where both cholesterol and triglycerides are high. Participants received either the drug or a placebo for 48 weeks while staying on a healthy diet. The goal was to see if plozasiran …
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:55 UTC
-
Massive chinese study reveals Real-World power of new cholesterol drugs
Disease control CompletedThis study looked at how well two types of cholesterol-lowering drugs (inclisiran and PCSK9 mAbs) work in everyday medical practice in China. Researchers analyzed health records from over 11,000 adults with high cholesterol. The goal was to see how much these drugs lower 'bad' ch…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New injection shows promise for controlling blood fats
Disease control CompletedThis study tested an experimental drug called ARO-ANG3 in 204 adults with mixed dyslipidemia, a condition where blood fats like triglycerides and cholesterol are too high. Participants received injections of the drug or a placebo to see if it safely lowers these fats. The goal is…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New cholesterol drug shows promise in indian patients
Disease control CompletedThis study looked at how safe and effective the drug inclisiran is for Indian adults with high cholesterol or mixed dyslipidemia. Sixty-five participants received the drug as a shot under the skin. Researchers tracked side effects and measured how much LDL (bad) cholesterol dropp…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New combo pill shows promise for stubborn high cholesterol
Disease control CompletedThis study tested whether a combination of two drugs (DW5421A and DW5421B) works better than one drug alone for lowering high cholesterol. 184 adults with high cholesterol or mixed lipid problems took part. The main goal was to see how much LDL (bad) cholesterol dropped after 8 w…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New cholesterol drug passes early safety check in healthy adults
Knowledge-focused CompletedThis early-stage study tested a new drug called DW5124 in 55 healthy adults to see how safe it is and how the body processes it. Researchers also checked if taking the drug with food changes its effects. The goal was to gather basic information before testing it in people with hi…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 07:53 UTC